Open this gap in the complete research map
Named evidence gapWhich treatment doses are effective and safe for confirmed Neocaridina health agents?
A precise unanswered question is part of the source of truth. It prevents an absent study, indirect result or popular rule from becoming false certainty.
This is a current search boundary, not proof that no study exists. The dated searches below show what was checked, which candidates were included or excluded and what evidence would change the answer.
Current boundary
One three-aquarium conference abstract reported complete Deugesia removal and three-day survival of all 12 shrimp after mebendazole or albendazole additions, but it omitted aquarium volume, usable concentration, replicated vessels, explicit control results, sublethal endpoints and recurrence follow-up. No controlled efficacy-and-safety trial was located for common hobby salt, fenbendazole, praziquantel or peroxide doses against named Neocaridina health agents.
What would answer it
Confirmed-agent trials with concentration verification, exposure duration, untreated controls, life-stage safety and recurrence follow-up.
Answerability brief
Specialist-led research is required
The question requires specialist identification, analytical verification, welfare oversight or treatment authority beyond an ordinary keeper observation.
Decision at stake: Whether a confirmed agent can be treated at a verified exposure while preserving shrimp welfare across life stages.
Primary endpoint: Confirmed agent clearance and recurrence, paired with survival, behavior, molting and reproduction safety endpoints.
Minimum design: Specialist-confirmed agent trials with untreated and vehicle controls, verified concentration and exposure, independently replicated systems, life-stage safety and prespecified rescue or stopping rules.
Required reporting: Agent identification and confirmation method, product and active ingredient, formulation, measured concentration, water chemistry, exposure and withdrawal, allocation, independent units, complete agent and animal denominators, adverse events, recurrence and professional oversight.
Community can contribute: Clear images, retained specimens and complete prior-treatment histories can improve agent identification and candidate-study selection through qualified channels.
Community observations cannot establish: A visual label, disappearance after dosing or survivor report cannot diagnose the agent, establish efficacy or authorize a dose.
Closure rule: A treatment claim requires confirmed-agent efficacy and shrimp safety for the exact formulation and exposure. Another organism, product or concentration does not inherit the result.
Open this question in the complete answerable research agenda.
Current research allocation
Qualified collaboration required
The current publisher cannot answer this alone. Work waits for suitable facilities, expertise, oversight and independently replicated units.
Why this allocation: Diagnosis, verified exposure, agent clearance and life-stage safety require specialist authority and cannot be crowdsourced through dosing reports.
Next permitted unit: Present the evidence gap and minimum design to an aquatic veterinarian, parasitologist or qualified disease laboratory for critique.
Activation trigger: A specialist can confirm the agent, authorize welfare safeguards and verify concentration in replicated controlled systems.
Stop decision: Do not recruit treatment trials, recommend a dose or reinterpret unconfirmed disappearance as efficacy. Keep immediate public guidance at identification and system triage.
Open this question in the complete finite research portfolio.
Reviewed: August 12, 2026.
Topics: Health, Chemical exposure
Practical guides governed by this gap
Reproducible search trail
Which common hobby treatments are both effective against confirmed targets and safe for Neocaridina?
Taxon names: Neocaridina davidi, Neocaridina heteropoda, Neocaridina denticulata sinensis.
Concepts: Scutariella japonica, Holtodrilus, Cladogonium, Deugesia, planaria, salt treatment, hydrogen peroxide, mebendazole, albendazole.
Search surfaces: publisher and DOI records, PubMed, scholarly web indexes, full-text repositories, multilingual university and journal repositories.
Outcome: A direct pilot abstract narrows the boundary for mebendazole and albendazole, but its incomplete dose, one-vessel-per-group design and three-day survival endpoint do not validate a treatment protocol. No controlled efficacy-and-host-safety trial for the named common hobby salt, fenbendazole, praziquantel or peroxide treatments was located. The gap remains open.
Exact queries and candidate decisions
Exact queries
Neocaridina davidi Scutariella japonica treatment salinity experimentNeocaridina heteropoda Holtodrilus treatment salt salinityNeocaridina denticulata sinensis parasite treatment efficacy saltNeocaridina davidi Cladogonium treatment hydrogen peroxide experimentNeocaridina antiparasitic treatment in vivo efficacyNeocaridina chemotherapy ectoparasite treatment bathNeocaridina planaria albendazol mebendazol experimento aquarioNeocaridina heteropoda mebendazolNeocaridina heteropoda albendazolNeocaridina traitement parasite antiparasitaire etude樱花虾 寄生虫 治疗 实验 盐 浸浴米虾 寄生虫 药物 治疗 试验
Candidate sources
- Breeding and life cycle of Neocaridina denticulata sinensis: excluded. Excluded from controlled treatment efficacy because the salinity response had no assigned treatment, untreated control, dose-duration or host-safety design. The paper is separately structured as bounded descriptive breeding and life-cycle evidence.
- Distribution of Holtodrilus truncatus with Reference to Salinity Tolerance and Host Preference: included. Included as organism ecology and isolated-worm physiology evidence, but excluded from host treatment efficacy because no attached Neocaridina or host-safety endpoint was tested.
- Epibiont Cohabitation in Freshwater Shrimp Neocaridina davidi: included. Included as direct survey, morphology and molt-observation evidence, but excluded from host treatment efficacy because microscopy isolation and removal were not an assigned controlled treatment.
- Utilizacao de vermicidas na eliminacao de planarias invasoras no cultivo do camarao Neocaridina heteropoda var. red: excluded. A direct three-aquarium, three-day conference abstract reports complete Deugesia removal and survival of all 12 shrimp after mebendazole or albendazole additions, but aquarium volume, usable concentration, explicit control results, replicated vessels, water chemistry, sublethal endpoints and recurrence are not reported.
Next scheduled search: February 12, 2027. Also governs: treatment-efficacy
Help close or refine this gap
Submit a stable source or correction. A title, abstract or community consensus does not close the gap until its methods and claim boundary are reviewed.